An expert discussion on the atypical hemolytic uremic syndrome nomenclature—identifying a road map to precision: a report of a National Kidney Foundation Working Group
The term atypical hemolytic uremic syndrome has been in use since the mid-1970s. It was initially used to describe the familial or sporadic form of hemolytic uremic syndrome as opposed to the epidemic, typical form of the disease. Over time, the atypical hemolytic uremic syndrome term has evolved in...
Gespeichert in:
| Veröffentlicht in: | Kidney international 2024-09, Vol.106 (3), p.326-336 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 336 |
|---|---|
| container_issue | 3 |
| container_start_page | 326 |
| container_title | Kidney international |
| container_volume | 106 |
| creator | Nester, Carla M. Feldman, David L. Burwick, Richard Cataland, Spero Chaturvedi, Shruti Cook, H. Terence Cuker, Adam Dixon, Bradley P. Fakhouri, Fadi Hingorani, Sangeeta R. Java, Anuja van de Kar, Nicole C.A.J. Kavanagh, David Leung, Nelson Licht, Christoph Noris, Marina O’Shaughnessy, Michelle M. Parikh, Samir V. Peyandi, Flora Remuzzi, Giuseppe Smith, Richard J.H. Sperati, C. John Waldman, Meryl Walker, Patrick Vivarelli, Marina |
| description | The term atypical hemolytic uremic syndrome has been in use since the mid-1970s. It was initially used to describe the familial or sporadic form of hemolytic uremic syndrome as opposed to the epidemic, typical form of the disease. Over time, the atypical hemolytic uremic syndrome term has evolved into being used to refer to anything that is not Shiga toxin–associated hemolytic uremic syndrome. The term describes a heterogeneous group of diseases of disparate causes, a circumstance that makes defining disease-specific natural history and/or targeted treatment approaches challenging. A working group of specialty-specific experts in the thrombotic microangiopathies was convened to review the validity of this broad term in an era of swiftly advancing science and targeted therapeutics. A Delphi approach was used to define and interrogate some of the key issues related to the atypical hemolytic uremic syndrome nomenclature. |
| doi_str_mv | 10.1016/j.kint.2024.05.021 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3096280642</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0085253824004022</els_id><sourcerecordid>3096280642</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1961-f7ed96ffce13dccdeaff92be19ad2a8968f40012acc815961e5e1d026563c1fb3</originalsourceid><addsrcrecordid>eNp9UcFu1DAQtRCILoUf4IB85JJgO-tsgrhUFS2ICi4gjpbXHlNvEzvYTkVufAQ_wW_xJUzYwhHJ8oxn3nsjzyPkKWc1Z7x9cahvfCi1YGJbM1kzwe-RDZeiqfhOyvtkw1gnKyGb7oQ8yvnA8N037CE5aXq-2_JebMjPs0Dh2wSpUOuzmXP2MVA85RqoLsvkjR7oNYxxWIo3dE4wYshLsCmOQANewQy6YOPX9x_eQijeLT58oZqmqC0d9URLpFMC41fxl2sDpogTo8P8vS5YxSHvvA2w0Is4B_unRj_HdLMqXaY4T4_JA6eHDE_u4in5dPH64_mb6urD5dvzs6vK8L7llduB7VvnDPDGGmNBO9eLPfBeW6G7vu3cljEutDEdl8gACdwy0cq2Mdztm1Py_Kg7pfh1hlzUiIuBYdAB4pxVw_pWdKzdCoSKI9SkmHMCp6bkR50WxZlaLVIHtVqkVosUkwotQtKzO_15P4L9R_nrCQJeHQGAv7z1kFQ2HpcM1uMOi7LR_0__N6tkqEs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3096280642</pqid></control><display><type>article</type><title>An expert discussion on the atypical hemolytic uremic syndrome nomenclature—identifying a road map to precision: a report of a National Kidney Foundation Working Group</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Nester, Carla M. ; Feldman, David L. ; Burwick, Richard ; Cataland, Spero ; Chaturvedi, Shruti ; Cook, H. Terence ; Cuker, Adam ; Dixon, Bradley P. ; Fakhouri, Fadi ; Hingorani, Sangeeta R. ; Java, Anuja ; van de Kar, Nicole C.A.J. ; Kavanagh, David ; Leung, Nelson ; Licht, Christoph ; Noris, Marina ; O’Shaughnessy, Michelle M. ; Parikh, Samir V. ; Peyandi, Flora ; Remuzzi, Giuseppe ; Smith, Richard J.H. ; Sperati, C. John ; Waldman, Meryl ; Walker, Patrick ; Vivarelli, Marina</creator><creatorcontrib>Nester, Carla M. ; Feldman, David L. ; Burwick, Richard ; Cataland, Spero ; Chaturvedi, Shruti ; Cook, H. Terence ; Cuker, Adam ; Dixon, Bradley P. ; Fakhouri, Fadi ; Hingorani, Sangeeta R. ; Java, Anuja ; van de Kar, Nicole C.A.J. ; Kavanagh, David ; Leung, Nelson ; Licht, Christoph ; Noris, Marina ; O’Shaughnessy, Michelle M. ; Parikh, Samir V. ; Peyandi, Flora ; Remuzzi, Giuseppe ; Smith, Richard J.H. ; Sperati, C. John ; Waldman, Meryl ; Walker, Patrick ; Vivarelli, Marina</creatorcontrib><description>The term atypical hemolytic uremic syndrome has been in use since the mid-1970s. It was initially used to describe the familial or sporadic form of hemolytic uremic syndrome as opposed to the epidemic, typical form of the disease. Over time, the atypical hemolytic uremic syndrome term has evolved into being used to refer to anything that is not Shiga toxin–associated hemolytic uremic syndrome. The term describes a heterogeneous group of diseases of disparate causes, a circumstance that makes defining disease-specific natural history and/or targeted treatment approaches challenging. A working group of specialty-specific experts in the thrombotic microangiopathies was convened to review the validity of this broad term in an era of swiftly advancing science and targeted therapeutics. A Delphi approach was used to define and interrogate some of the key issues related to the atypical hemolytic uremic syndrome nomenclature.</description><identifier>ISSN: 0085-2538</identifier><identifier>ISSN: 1523-1755</identifier><identifier>EISSN: 1523-1755</identifier><identifier>DOI: 10.1016/j.kint.2024.05.021</identifier><identifier>PMID: 39174192</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Atypical Hemolytic Uremic Syndrome - diagnosis ; Atypical Hemolytic Uremic Syndrome - genetics ; complement ; Consensus ; Delphi Technique ; hemolytic uremic syndrome ; Humans ; Nephrology - standards ; nomenclature ; Terminology as Topic ; thrombotic microangiopathy</subject><ispartof>Kidney international, 2024-09, Vol.106 (3), p.326-336</ispartof><rights>2024 International Society of Nephrology</rights><rights>Copyright © 2024 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1961-f7ed96ffce13dccdeaff92be19ad2a8968f40012acc815961e5e1d026563c1fb3</cites><orcidid>0000-0003-4168-3277 ; 0000-0002-2448-1959 ; 0000-0003-3704-0922 ; 0000-0002-8409-0714 ; 0000-0002-5651-1411 ; 0000-0001-7651-5033 ; 0000-0001-8698-0502</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39174192$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nester, Carla M.</creatorcontrib><creatorcontrib>Feldman, David L.</creatorcontrib><creatorcontrib>Burwick, Richard</creatorcontrib><creatorcontrib>Cataland, Spero</creatorcontrib><creatorcontrib>Chaturvedi, Shruti</creatorcontrib><creatorcontrib>Cook, H. Terence</creatorcontrib><creatorcontrib>Cuker, Adam</creatorcontrib><creatorcontrib>Dixon, Bradley P.</creatorcontrib><creatorcontrib>Fakhouri, Fadi</creatorcontrib><creatorcontrib>Hingorani, Sangeeta R.</creatorcontrib><creatorcontrib>Java, Anuja</creatorcontrib><creatorcontrib>van de Kar, Nicole C.A.J.</creatorcontrib><creatorcontrib>Kavanagh, David</creatorcontrib><creatorcontrib>Leung, Nelson</creatorcontrib><creatorcontrib>Licht, Christoph</creatorcontrib><creatorcontrib>Noris, Marina</creatorcontrib><creatorcontrib>O’Shaughnessy, Michelle M.</creatorcontrib><creatorcontrib>Parikh, Samir V.</creatorcontrib><creatorcontrib>Peyandi, Flora</creatorcontrib><creatorcontrib>Remuzzi, Giuseppe</creatorcontrib><creatorcontrib>Smith, Richard J.H.</creatorcontrib><creatorcontrib>Sperati, C. John</creatorcontrib><creatorcontrib>Waldman, Meryl</creatorcontrib><creatorcontrib>Walker, Patrick</creatorcontrib><creatorcontrib>Vivarelli, Marina</creatorcontrib><title>An expert discussion on the atypical hemolytic uremic syndrome nomenclature—identifying a road map to precision: a report of a National Kidney Foundation Working Group</title><title>Kidney international</title><addtitle>Kidney Int</addtitle><description>The term atypical hemolytic uremic syndrome has been in use since the mid-1970s. It was initially used to describe the familial or sporadic form of hemolytic uremic syndrome as opposed to the epidemic, typical form of the disease. Over time, the atypical hemolytic uremic syndrome term has evolved into being used to refer to anything that is not Shiga toxin–associated hemolytic uremic syndrome. The term describes a heterogeneous group of diseases of disparate causes, a circumstance that makes defining disease-specific natural history and/or targeted treatment approaches challenging. A working group of specialty-specific experts in the thrombotic microangiopathies was convened to review the validity of this broad term in an era of swiftly advancing science and targeted therapeutics. A Delphi approach was used to define and interrogate some of the key issues related to the atypical hemolytic uremic syndrome nomenclature.</description><subject>Atypical Hemolytic Uremic Syndrome - diagnosis</subject><subject>Atypical Hemolytic Uremic Syndrome - genetics</subject><subject>complement</subject><subject>Consensus</subject><subject>Delphi Technique</subject><subject>hemolytic uremic syndrome</subject><subject>Humans</subject><subject>Nephrology - standards</subject><subject>nomenclature</subject><subject>Terminology as Topic</subject><subject>thrombotic microangiopathy</subject><issn>0085-2538</issn><issn>1523-1755</issn><issn>1523-1755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UcFu1DAQtRCILoUf4IB85JJgO-tsgrhUFS2ICi4gjpbXHlNvEzvYTkVufAQ_wW_xJUzYwhHJ8oxn3nsjzyPkKWc1Z7x9cahvfCi1YGJbM1kzwe-RDZeiqfhOyvtkw1gnKyGb7oQ8yvnA8N037CE5aXq-2_JebMjPs0Dh2wSpUOuzmXP2MVA85RqoLsvkjR7oNYxxWIo3dE4wYshLsCmOQANewQy6YOPX9x_eQijeLT58oZqmqC0d9URLpFMC41fxl2sDpogTo8P8vS5YxSHvvA2w0Is4B_unRj_HdLMqXaY4T4_JA6eHDE_u4in5dPH64_mb6urD5dvzs6vK8L7llduB7VvnDPDGGmNBO9eLPfBeW6G7vu3cljEutDEdl8gACdwy0cq2Mdztm1Py_Kg7pfh1hlzUiIuBYdAB4pxVw_pWdKzdCoSKI9SkmHMCp6bkR50WxZlaLVIHtVqkVosUkwotQtKzO_15P4L9R_nrCQJeHQGAv7z1kFQ2HpcM1uMOi7LR_0__N6tkqEs</recordid><startdate>202409</startdate><enddate>202409</enddate><creator>Nester, Carla M.</creator><creator>Feldman, David L.</creator><creator>Burwick, Richard</creator><creator>Cataland, Spero</creator><creator>Chaturvedi, Shruti</creator><creator>Cook, H. Terence</creator><creator>Cuker, Adam</creator><creator>Dixon, Bradley P.</creator><creator>Fakhouri, Fadi</creator><creator>Hingorani, Sangeeta R.</creator><creator>Java, Anuja</creator><creator>van de Kar, Nicole C.A.J.</creator><creator>Kavanagh, David</creator><creator>Leung, Nelson</creator><creator>Licht, Christoph</creator><creator>Noris, Marina</creator><creator>O’Shaughnessy, Michelle M.</creator><creator>Parikh, Samir V.</creator><creator>Peyandi, Flora</creator><creator>Remuzzi, Giuseppe</creator><creator>Smith, Richard J.H.</creator><creator>Sperati, C. John</creator><creator>Waldman, Meryl</creator><creator>Walker, Patrick</creator><creator>Vivarelli, Marina</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4168-3277</orcidid><orcidid>https://orcid.org/0000-0002-2448-1959</orcidid><orcidid>https://orcid.org/0000-0003-3704-0922</orcidid><orcidid>https://orcid.org/0000-0002-8409-0714</orcidid><orcidid>https://orcid.org/0000-0002-5651-1411</orcidid><orcidid>https://orcid.org/0000-0001-7651-5033</orcidid><orcidid>https://orcid.org/0000-0001-8698-0502</orcidid></search><sort><creationdate>202409</creationdate><title>An expert discussion on the atypical hemolytic uremic syndrome nomenclature—identifying a road map to precision: a report of a National Kidney Foundation Working Group</title><author>Nester, Carla M. ; Feldman, David L. ; Burwick, Richard ; Cataland, Spero ; Chaturvedi, Shruti ; Cook, H. Terence ; Cuker, Adam ; Dixon, Bradley P. ; Fakhouri, Fadi ; Hingorani, Sangeeta R. ; Java, Anuja ; van de Kar, Nicole C.A.J. ; Kavanagh, David ; Leung, Nelson ; Licht, Christoph ; Noris, Marina ; O’Shaughnessy, Michelle M. ; Parikh, Samir V. ; Peyandi, Flora ; Remuzzi, Giuseppe ; Smith, Richard J.H. ; Sperati, C. John ; Waldman, Meryl ; Walker, Patrick ; Vivarelli, Marina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1961-f7ed96ffce13dccdeaff92be19ad2a8968f40012acc815961e5e1d026563c1fb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Atypical Hemolytic Uremic Syndrome - diagnosis</topic><topic>Atypical Hemolytic Uremic Syndrome - genetics</topic><topic>complement</topic><topic>Consensus</topic><topic>Delphi Technique</topic><topic>hemolytic uremic syndrome</topic><topic>Humans</topic><topic>Nephrology - standards</topic><topic>nomenclature</topic><topic>Terminology as Topic</topic><topic>thrombotic microangiopathy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nester, Carla M.</creatorcontrib><creatorcontrib>Feldman, David L.</creatorcontrib><creatorcontrib>Burwick, Richard</creatorcontrib><creatorcontrib>Cataland, Spero</creatorcontrib><creatorcontrib>Chaturvedi, Shruti</creatorcontrib><creatorcontrib>Cook, H. Terence</creatorcontrib><creatorcontrib>Cuker, Adam</creatorcontrib><creatorcontrib>Dixon, Bradley P.</creatorcontrib><creatorcontrib>Fakhouri, Fadi</creatorcontrib><creatorcontrib>Hingorani, Sangeeta R.</creatorcontrib><creatorcontrib>Java, Anuja</creatorcontrib><creatorcontrib>van de Kar, Nicole C.A.J.</creatorcontrib><creatorcontrib>Kavanagh, David</creatorcontrib><creatorcontrib>Leung, Nelson</creatorcontrib><creatorcontrib>Licht, Christoph</creatorcontrib><creatorcontrib>Noris, Marina</creatorcontrib><creatorcontrib>O’Shaughnessy, Michelle M.</creatorcontrib><creatorcontrib>Parikh, Samir V.</creatorcontrib><creatorcontrib>Peyandi, Flora</creatorcontrib><creatorcontrib>Remuzzi, Giuseppe</creatorcontrib><creatorcontrib>Smith, Richard J.H.</creatorcontrib><creatorcontrib>Sperati, C. John</creatorcontrib><creatorcontrib>Waldman, Meryl</creatorcontrib><creatorcontrib>Walker, Patrick</creatorcontrib><creatorcontrib>Vivarelli, Marina</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Kidney international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nester, Carla M.</au><au>Feldman, David L.</au><au>Burwick, Richard</au><au>Cataland, Spero</au><au>Chaturvedi, Shruti</au><au>Cook, H. Terence</au><au>Cuker, Adam</au><au>Dixon, Bradley P.</au><au>Fakhouri, Fadi</au><au>Hingorani, Sangeeta R.</au><au>Java, Anuja</au><au>van de Kar, Nicole C.A.J.</au><au>Kavanagh, David</au><au>Leung, Nelson</au><au>Licht, Christoph</au><au>Noris, Marina</au><au>O’Shaughnessy, Michelle M.</au><au>Parikh, Samir V.</au><au>Peyandi, Flora</au><au>Remuzzi, Giuseppe</au><au>Smith, Richard J.H.</au><au>Sperati, C. John</au><au>Waldman, Meryl</au><au>Walker, Patrick</au><au>Vivarelli, Marina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An expert discussion on the atypical hemolytic uremic syndrome nomenclature—identifying a road map to precision: a report of a National Kidney Foundation Working Group</atitle><jtitle>Kidney international</jtitle><addtitle>Kidney Int</addtitle><date>2024-09</date><risdate>2024</risdate><volume>106</volume><issue>3</issue><spage>326</spage><epage>336</epage><pages>326-336</pages><issn>0085-2538</issn><issn>1523-1755</issn><eissn>1523-1755</eissn><abstract>The term atypical hemolytic uremic syndrome has been in use since the mid-1970s. It was initially used to describe the familial or sporadic form of hemolytic uremic syndrome as opposed to the epidemic, typical form of the disease. Over time, the atypical hemolytic uremic syndrome term has evolved into being used to refer to anything that is not Shiga toxin–associated hemolytic uremic syndrome. The term describes a heterogeneous group of diseases of disparate causes, a circumstance that makes defining disease-specific natural history and/or targeted treatment approaches challenging. A working group of specialty-specific experts in the thrombotic microangiopathies was convened to review the validity of this broad term in an era of swiftly advancing science and targeted therapeutics. A Delphi approach was used to define and interrogate some of the key issues related to the atypical hemolytic uremic syndrome nomenclature.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>39174192</pmid><doi>10.1016/j.kint.2024.05.021</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-4168-3277</orcidid><orcidid>https://orcid.org/0000-0002-2448-1959</orcidid><orcidid>https://orcid.org/0000-0003-3704-0922</orcidid><orcidid>https://orcid.org/0000-0002-8409-0714</orcidid><orcidid>https://orcid.org/0000-0002-5651-1411</orcidid><orcidid>https://orcid.org/0000-0001-7651-5033</orcidid><orcidid>https://orcid.org/0000-0001-8698-0502</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0085-2538 |
| ispartof | Kidney international, 2024-09, Vol.106 (3), p.326-336 |
| issn | 0085-2538 1523-1755 1523-1755 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3096280642 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Atypical Hemolytic Uremic Syndrome - diagnosis Atypical Hemolytic Uremic Syndrome - genetics complement Consensus Delphi Technique hemolytic uremic syndrome Humans Nephrology - standards nomenclature Terminology as Topic thrombotic microangiopathy |
| title | An expert discussion on the atypical hemolytic uremic syndrome nomenclature—identifying a road map to precision: a report of a National Kidney Foundation Working Group |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T06%3A36%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20expert%20discussion%20on%20the%20atypical%20hemolytic%20uremic%20syndrome%20nomenclature%E2%80%94identifying%20a%20road%20map%20to%20precision:%20a%20report%20of%20a%20National%20Kidney%20Foundation%20Working%20Group&rft.jtitle=Kidney%20international&rft.au=Nester,%20Carla%20M.&rft.date=2024-09&rft.volume=106&rft.issue=3&rft.spage=326&rft.epage=336&rft.pages=326-336&rft.issn=0085-2538&rft.eissn=1523-1755&rft_id=info:doi/10.1016/j.kint.2024.05.021&rft_dat=%3Cproquest_cross%3E3096280642%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3096280642&rft_id=info:pmid/39174192&rft_els_id=S0085253824004022&rfr_iscdi=true |